UBS AG - SAGENT PHARMACEUTICALS INC ownership

SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 98 filers reported holding SAGENT PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS AG ownership history of SAGENT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2014$16,000
+23.1%
5130.0%0.00%
Q2 2014$13,000
-53.6%
513
-57.5%
0.00%
Q1 2014$28,000
-37.8%
1,206
-45.5%
0.00%
Q3 2013$45,0002,2120.00%
Other shareholders
SAGENT PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Timpani Capital Management LLC 110,215$2,248,0001.32%
Healthcare Value Capital, LLC 73,822$1,506,0001.32%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,014,863$20,703,0000.96%
Perimeter Capital Partners, LLC 248,893$5,077,0000.94%
Tekla Capital Management LLC 270,031$5,509,0000.61%
SECTORAL ASSET MANAGEMENT INC 564,325$11,512,0000.55%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 168,268$3,432,0000.35%
MENTA CAPITAL LLC 30,480$622,0000.32%
KOPP INVESTMENT ADVISORS LLC 39,934$815,0000.30%
Broadfin Capital, LLC 68,300$1,393,0000.25%
View complete list of SAGENT PHARMACEUTICALS INC shareholders